EUVIMEDEUVIMED entdecken
Leitlinie

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1

Rahul Banerjee iD, Matthew C Cheung, Benjamin Derman iD, Hans Messersmith iD, Samer Al Hadidi iD, Sita Bhella, Cynthia Chmielewski, Mohammad S Ebraheem iD, C Todd Kennedy iD, Shaji Kumar iD, Alan Langerak, Brea Lipe iD und 9 weitere

Journal of Clinical Oncology · 01.08.2026 · 44 (22)

DOI: 10.1200/jco-26-01139 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.08.2026. Verfasst von Rahul Banerjee und 20 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Center, Seattle, WA. Hauptthemen laut MEDLINE: Multiple Myeloma, Practice Guidelines as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This guideline has been updated. This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 ). Updates are published regularly and can be found on the ASCO Publications website .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaPractice Guidelines as TopicHumans

Autor:innen und Institutionen

  • Fred Hutchinson Cancer Center, Seattle, WA.
  • Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • University of Chicago, Chicago, IL.
  • American Society of Clinical Oncology (ASCO), Alexandria, VA.
  • University of Texas Southwestern Medical Center, Dallas, TX.
  • Princess Margaret Cancer Centre, Toronto, ON, Canada.

ORCID-Profile: Rahul Banerjee, Benjamin Derman, Hans Messersmith, Samer Al Hadidi, Mohammad S Ebraheem, C Todd Kennedy, Shaji Kumar, Brea Lipe, Hira Mian, Eloisa Riva, Saad Z Usmani, Tanya M Wildes, Saurabh Zanwar, Lisa K Hicks

Zitieren

APA

Banerjee, R., Cheung, M. C., Derman, B., Messersmith, H., Al Hadidi, S., Bhella, S., Chmielewski, C., Ebraheem, M. S., Kennedy, C. T., Kumar, S., Langerak, A., Lipe, B., Mian, H., Riva, E., Seth, R., Subramanian, L., Usmani, S. Z., Wildes, T. M., Zanwar, S., …, & Hicks, L. K. (2026). Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1. Journal of Clinical Oncology, 44(22). https://doi.org/10.1200/jco-26-01139

Vancouver

Banerjee R, Cheung MC, Derman B, Messersmith H, Al Hadidi S, Bhella S, et al. Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1. Journal of Clinical Oncology. 2026;44(22). doi:10.1200/jco-26-01139

BibTeX
@article{Banerjee2026,
  author = {Banerjee, Rahul and Cheung, Matthew C and Derman, Benjamin and Messersmith, Hans and Al Hadidi, Samer and Bhella, Sita and Chmielewski, Cynthia and Ebraheem, Mohammad S and Kennedy, C Todd and Kumar, Shaji and Langerak, Alan and Lipe, Brea and Mian, Hira and Riva, Eloisa and Seth, Rahul and Subramanian, Latha and Usmani, Saad Z and Wildes, Tanya M and Zanwar, Saurabh and Zhuo, Ying and Hicks, Lisa K},
  title = {Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {22},
  doi = {10.1200/jco-26-01139}
}
Kostenlos starten →